Bioventus Inc. has grown revenue 4.5% a year over three years and 9.1% a year over five. Revenue growth, 3-year annual rate: +4.5% (Medical Devices median +12%). Revenue growth, 5-year rate: +9.1%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

BVSBioventus Inc.

Healthcare

$12.70+91% 1Y

$12.70

$6.5152 weeks$15.30

Is it growing?

Mixed

Neither accelerating nor breaking down: operating margin widening (+3.8 points), but earnings down −7800% year on year.

1 good, 1 to watch, 1 neutral

Revenue trend+3% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +9% a year.

Earnings trend−7800% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+3.8 points operating

Trailing-twelve-month operating margin, 9.8% now against 6.0% a year earlier.

All from SEC EDGAR, as of Jun 27, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BVS growing?

Bioventus Inc. has grown revenue 4.5% a year over three years and 9.1% a year over five.

+4.5%

Revenue growth, 3-year annual rate · Medical Devices median +12% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +9.1%
Revenue growth, 5-year rate · +4.5% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›